Clearside Biomedical, Inc. (CLSD)
NASDAQ: CLSD · Real-Time Price · USD
0.7399
-0.0211 (-2.77%)
At close: Jun 2, 2025, 4:00 PM
0.7350
-0.0049 (-0.66%)
After-hours: Jun 2, 2025, 7:59 PM EDT

Clearside Biomedical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-30.81-34.35-32.49-32.950.38-18.21
Upgrade
Depreciation & Amortization
0.280.230.070.150.180.18
Upgrade
Other Amortization
-----0.13
Upgrade
Loss (Gain) From Sale of Assets
---0.03--
Upgrade
Stock-Based Compensation
4.174.514.24.885.053.6
Upgrade
Other Operating Activities
5.166.599.363.28-10.06
Upgrade
Change in Accounts Payable
-0.11-1.430.610.690.68-0.63
Upgrade
Change in Unearned Revenue
-0.15-0.08-0.130.21-5-
Upgrade
Change in Other Net Operating Assets
-1.22-0.170.2410.34-11.021.75
Upgrade
Operating Cash Flow
-22.68-24.7-18.14-13.37-10.73-13.12
Upgrade
Capital Expenditures
-0.93-0.98-1.78-0.25--0.06
Upgrade
Investment in Securities
0.340.34----
Upgrade
Investing Cash Flow
-0.59-0.64-1.78-0.25--0.06
Upgrade
Long-Term Debt Issued
-----0.99
Upgrade
Long-Term Debt Repaid
------5.34
Upgrade
Net Debt Issued (Repaid)
------4.35
Upgrade
Issuance of Common Stock
2.5416.441.760.723.7812.22
Upgrade
Other Financing Activities
-1--1.3530.64--
Upgrade
Financing Cash Flow
1.5416.440.4131.3323.787.87
Upgrade
Net Cash Flow
-21.73-8.9-19.517.7213.05-5.31
Upgrade
Free Cash Flow
-23.61-25.68-19.91-13.61-10.73-13.18
Upgrade
Free Cash Flow Margin
-627.15%-1542.97%-242.06%-1025.70%-36.29%-166.90%
Upgrade
Free Cash Flow Per Share
-0.31-0.35-0.32-0.23-0.18-0.28
Upgrade
Cash Interest Paid
-----0.52
Upgrade
Levered Free Cash Flow
-21.45-22.48-17.93-4.49-10.35-6.4
Upgrade
Unlevered Free Cash Flow
-15.17-16.37-12.08-2.4-10.35-6.32
Upgrade
Change in Net Working Capital
2.532.08-0.96-11.7415.2-1.16
Upgrade
Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q